ORGANICELL™ REGENERATIVE MEDICINE

OUR COVID-19 PROGRAM

Organicell™ has recently received an approval notification from the FDA for its investigational new drug (IND) application investigating their lead product, Zofin™, for patients diagnosed with moderate to severe acute respiratory syndrome (SARS) due to COVID-19 infection. This trial will be the first randomized, double-blinded, placebo-controlled, phase I/II multi-center clinical trial investigating the safety and potential efficacy of perinatal sourced components for COVID-19.

Organicell™ is the leading, fully integrated Regenerative Medicine Company. Our world class research, technology, manufacturing, and clinical development team is focused on creating new regenerative medicine.

We believe that our ground-breaking research in the field of nanotechnology, specifically extracellular vesicles and perinatal-derived nanoparticles, is the next frontier of regenerative therapeutics. Organicell™ is committed to creating life changing and lifesaving therapies for patients.

LEARN MORE
THE NEXT GENERATION OF

BIOLOGIC MEDICINE

Organicell™ is the leading, fully integrated Biologic Medicine Company. Our world class research, technology, manufacturing and clinical development team is focused on creating new biologic medicine.

We believe that our ground-breaking research in the field of nanotechnology, specifically extracellular vesicles and perinatal-derived nanoparticles, is the next frontier of biological therapeutics. Organicell™ is committed to creating life changing and lifesaving therapies for patients

LEARN MORE
We have developed new technologies in Biologic Medicine

NANO-PARTICLES
THERAPEUTICS

LEARN MORE

We have developed new technologies in Biologic Medicine

NANO-PARTICLES
THERAPEUTICS

LEARN MORE
ORGANICELL™ BIOLOGICS

OUR MISSION

Our mission is to transform regenerative medicine through the development of novel nano-technologies and to become the health care incubator for the next generation of biologic medicines.

MEET OUR TEAM
ORGANICELL™ BIOLOGICS

OUR MISSION

Our mission is to transform regenerative medicine by continuing to combine nano- technology with other synergistic therapies and become the healthcare incubator for biologic medicine.

MEET OUR TEAM

THE ORGANICELL™ DIFFERENCE

  • Isolating the nanoparticles containing miRNA and using them as the next generation of biological medicine.
  • Targeted cells will react to these messaging signals and will change their behavior accordingly.
    There is a tremendous therapeutic potential of extracellular vesicles and nano-particles.
  • Patent Pending Technology.
  • Ongoing Clinical Trials.

We Believe We Have Found The Key To Consistent
Patient Outcomes

NANO-TECHNOLOGY

THE ORGANICELL™ DIFFERENCE

  • Isolating the therapeutic signals released by regenerative cells, and using them rather than the cells themselves are the next generation as a therapy.
  • Targeted cells will react to these messaging signals and will change their behavior accordingly. There is a tremendous therapeutic potential of extracellular vesicles and nano-particles.
  • Zofin™ & Organicell™ Factor X are NOT culture expanded
  • Patent Pending Technology.
  • Ongoing Clinical Trials.

We Believe We Have Found The Key To Consistent
Patient Outcomes

NANO-TECHNOLOGY

CONTACT US

Organicell™ is a US publicly traded science based company focusing on research, development, marketing and manufacturing. We specialize in Regenerative Medicine management. Our goal is to further advance the clinical knowledge in regenerative medicine.

PHONE

(888)963-7881

EMAIL ADDRESS

info@organicell.com

Maps were disabled by the visitor on this site. Click to open the map in a new window.

Maps were disabled by the visitor on this site. Click to open the map in a new window.

LET’S STAY CONNECTED

Newsletter

© 2020 Organicell ™ | All rights reserved. Privacy Policy.